EUVIMEDEUVIMED entdecken
Open Access

Herpes simplex virus type 2: Seroprevalence in antenatal women

Shagufta Rathore, Aditi Jamwal, Vipin Gupta

Indian Journal of Sexually Transmitted Diseases and AIDS · 2010 · 31 (1) · 11

DOI: 10.4103/0253-7184.68994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Sexually Transmitted Diseases and AIDS, 2010. Verfasst von Shagufta Rathore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Government Medical College and Hospital, Jammu - 180 001, Jammu & Kashmir, India. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: To determine the seroprevalence of herpes simplex type 2 (HSV-2) infection in pregnant females, assess the frequency of unrecognized infection and identify the demographic profile and risk factors associated with the seroprevalence. MATERIALS AND METHODS: Two hundred randomly selected, asymptomatic pregnant females attending the Obstetrics and Gynecology Outpatient Department for a routine antenatal check-up constituted the study group. Serum specimens were screened for HSV-2 infection by detecting IgG class antibodies against HSV-2-specific glycoprotein G-2 using an enzyme-linked immunosorbent assay kit. RESULTS: A seroprevalence of 7.5% was found in our study. Seropositivity was maximum in the age group ≥30 years (22.20%), followed by 26-30 years (9.7%), 21-25 years (2.20%) and ≤20 years (0%). HSV-2 seropositivity was found to be significantly associated with increasing age, parity, number of sexual partners, duration of sexual activity and history of abortions (P 0.05). No statistically significant association of seropositivity with present or past history suggestive of other sexually transmitted infections was found. None of our cases tested positive for human immunodeficiency syndrome (HIV). CONCLUSION: A relatively low prevalence of HSV-2 seropositivity was found in our study, with a high frequency of unrecognized and asymptomatic infections. Our findings suggest that type-specific serotesting could be an efficient strategy to diagnose clinically asymptomatic HSV-2 infections and, therefore, to reduce the risk of HSV-2 and HIV sexual transmission by prophylactic counseling against unprotected intercourse. It may also be a useful adjunct in detecting cases who present with symptoms not directly suggestive of genital herpes.

Schlagwörter

Stichwörter der Autor:innen

Herpes simplex virus type 2pregnant womenseroprevalence

Autor:innen und Institutionen

  • Department of Dermatology, Government Medical College and Hospital, Jammu - 180 001, Jammu & Kashmir, India.

Zitieren

APA

Rathore, S., Jamwal, A., & Gupta, V. (2010). Herpes simplex virus type 2: Seroprevalence in antenatal women. Indian Journal of Sexually Transmitted Diseases and AIDS, 31(1), 11. https://doi.org/10.4103/0253-7184.68994

Vancouver

Rathore S, Jamwal A, Gupta V. Herpes simplex virus type 2: Seroprevalence in antenatal women. Indian Journal of Sexually Transmitted Diseases and AIDS. 2010;31(1):11. doi:10.4103/0253-7184.68994

BibTeX
@article{Rathore2010,
  author = {Rathore, Shagufta and Jamwal, Aditi and Gupta, Vipin},
  title = {Herpes simplex virus type 2: Seroprevalence in antenatal women},
  journal = {Indian Journal of Sexually Transmitted Diseases and AIDS},
  year = {2010},
  volume = {31},
  number = {1},
  pages = {11},
  doi = {10.4103/0253-7184.68994}
}
Kostenlos starten →